| 14th Mar 2025 7:01 am |
RNS |
Transaction in Own Shares |
| 14th Mar 2025 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
| 13th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 10th Mar 2025 7:00 am |
RNS |
Notice of Annual Results |
| 7th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 26th Feb 2025 7:00 am |
RNS |
RTW CIO increases position to 15% |
| 25th Feb 2025 1:00 pm |
RNS |
Material purchase by CIO of the Investment Manager |
| 17th Feb 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
| 14th Feb 2025 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
| 28th Jan 2025 7:00 am |
RNS |
Material Update from Portfolio Company |
| 27th Jan 2025 7:00 am |
RNS |
Kailera Reports Positive Data in Ph2 Obesity Trial |
| 17th Jan 2025 7:01 am |
RNS |
New Investment in Series A of Windward Bio |
| 17th Jan 2025 7:00 am |
RNS |
Additional Investment in Umoja Biopharma |
| 15th Jan 2025 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
| 14th Jan 2025 7:00 am |
RNS |
Additional Investment in Numab Therapeutics |
| 10th Jan 2025 7:00 am |
RNS |
New Investment in Series A of Alesta Therapeutics |
| 30th Dec 2024 7:00 am |
RNS |
CORXEL Announces Two Significant Transactions |
| 20th Dec 2024 12:15 pm |
RNS |
New Investment in Series A of Ottimo Pharma |
| 13th Dec 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
| 10th Dec 2024 12:00 pm |
RNS |
Holding(s) in Company |
| 10th Dec 2024 7:00 am |
RNS |
Appointment of Senior Independent Director |
| 15th Nov 2024 7:00 am |
RNS |
CORXEL Announces Acceptance of NDA for Aficamten |
| 14th Nov 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
| 1st Nov 2024 2:00 pm |
RNS |
New Investment in Series C Round of Evommune, Inc. |
| 1st Nov 2024 7:00 am |
RNS |
RTW Biotech Opportunities’ 5th Anniversary |
| 14th Oct 2024 6:12 pm |
RNS |
Monthly Valuation Update and Factsheet Replacement |
| 14th Oct 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
| 3rd Oct 2024 7:00 am |
RNS |
Launch of Obesity Company Kailera Therapeutics |
| 2nd Oct 2024 7:00 am |
RNS |
New Investment in Aktis Oncology |
| 27th Sep 2024 7:00 am |
RNS |
BioAge Labs completes $198 million IPO |
| 26th Sep 2024 7:00 am |
RNS |
GBP quote for the share class to cease |
| 16th Sep 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
| 13th Sep 2024 7:00 am |
RNS |
Half-year Report |
| 14th Aug 2024 7:01 am |
RNS |
Closed Period Notification |
| 14th Aug 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
| 6th Aug 2024 7:00 am |
RNS |
New Investment in Jade Biosciences, Inc |
| 22nd Jul 2024 12:00 pm |
RNS |
Artiva Biotherapeutics prices IPO at $167 million |
| 15th Jul 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
| 11th Jul 2024 7:00 am |
RNS |
Baroness Blackwood Appointed as Independent NED |
| 2nd Jul 2024 7:00 am |
RNS |
Investment in Mirador Therapeutics & Santa Ana Bio |
